UP-024-c01 Uro-oncology early
Intravesical BCG therapy
BCG cystitis and severe lower-tract symptoms
Immune-mediated bladder inflammation can cause dysuria, frequency, urgency, haematuria and pain that may limit treatment.
This module records catalogue coverage only. Do not use it to make diagnosis or treatment decisions.
Interactive 3D The operation this complication belongs to: Intravesical BCG therapy Interactive BCG instillation model Open the 3D animation 01 Variation coverage
Which versions of the operation this applies to
BCG induction courseBCG maintenance courseRisk-adapted modified BCG pathway
The parent hub contains 3 recorded variations.
The labels above prevent a complication from being implied for an approach where it is not relevant.
02 Evidence
Sources
European Association of Urology EAU Guidelines on Non-muscle-invasive Bladder Cancer
TURBT quality, repeat resection and intravesical-treatment pathways.
Accessed 2026-08-03 · opens source European Association of Urology EAU Guidelines on Urological InfectionsInfection prevention, recognition and procedure-associated infection context.
Accessed 2026-08-03 · opens source British Association of Urological Surgeons Patient information leaflets by procedureUK patient-facing procedure, alternatives, recovery and complication framing.
Accessed 2026-08-03 · opens source03 Same procedure
Other Intravesical BCG complication modules
multiple Systemic BCG infection or inflammatory syndrome immediate Traumatic catheterisation with systemic exposure early Urinary bacterial infection late Granulomatous prostatitis, epididymo-orchitis or upper-tract involvement late Bladder contracture or reduced capacity late Treatment interruption or incomplete oncological course immediate Occupational or household exposure
Return to the complete procedure hub